StockNews.com assumed coverage on shares of NanoString Technologies (NASDAQ:NSTG – Free Report) in a report issued on Wednesday morning. The firm issued a sell rating on the biotechnology company’s stock. A number of other equities analysts also recently commented on the company. Morgan Stanley decreased their target price on NanoString Technologies from $14.00 to $8.00 […]